CARERATING
Care Ratings
Each stock's 10,000-path forecast, rendered as light.
Care Ratings (CARERATING) Stock Analysis & Case Study
Is CARERATING a good buy? The data-driven verdict.
Care Ratings (CARERATING) trades at ₹1,724,on the numbers it worth a closer look, a Downstox Snapshot Score of 66/100.
On the numbers, Care Ratings (CARERATING) worth a closer look, a Downstox Snapshot Score of 66/100, weighing premium at 30.2× earnings, ROE of 19.7%, a 68% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
CARERATING fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is CARERATING overvalued? CARERATING P/E vs its sector
CARERATING's P/E of 30.2× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers, while its 1.28% dividend yield is below the peer median of 1.65%.
CARERATING share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of CARERATING history (24%/yr drift, 38%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| CARERATING 2027 | ₹1,248 | ₹2,038 | ₹3,296 | +19% |
| CARERATING 2028 | ₹1,207 | ₹2,415 | ₹4,850 | +41% |
| CARERATING 2029 | ₹1,216 | ₹2,843 | ₹6,551 | +66% |
| CARERATING 2030 | ₹1,249 | ₹3,386 | ₹8,950 | +98% |
| CARERATING 2031 | ₹1,333 | ₹4,069 | ₹11,865 | +137% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability CARERATING goes up, or doubles?
The bull case for CARERATING
- High return on equity (19.7%), the business compounds shareholder capital efficiently, the hallmark of a quality franchise.
- Strong ROCE (26.3%) shows the core business earns well above its cost of capital.
- A 10,000-path probability model puts a 68% chance the price is higher in a year, with a median target of ₹2,038 (+19%).
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹6,551.
The bear case & risks
- At 30.2× earnings the stock carries a premium to the market, strong growth is already in the price, so any miss tends to be punished.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹1,216.
CARERATING volatility & expected range, how bumpy is the ride?
Over the last 2.0 years CARERATING compounded at 24%/year with annualized volatility of 38%. That volatility implies a 1-year 80% range of ₹1,248–₹3,296, the honest backbone behind any single price target.
CARERATING price forecast, the full 60-month probability fan
CARERATING price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds CARERATING hits common targets within the simulated horizon?
Full multi-horizon detail on the CARERATING price target & forecast page.
CARERATING Piotroski F-Score: 4/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. CARERATING scores 4/9,mixed financial health.
CARERATING MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy CARERATING with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 31.8% | 3.1× |
| DhanCHEAPEST | 31.8% | 3.1× |
Compare every broker on the CARERATING MTF page.
CARERATING vs peers,sector comparison
About Care Ratings: sector, index & market-cap context
Care Ratings (CARERATING) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹5,165 Cr. See more Nifty 500 stocks.
How the CARERATING Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Care Ratings's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
CARERATING analysis, FAQs
Is Care Ratings (CARERATING) a good buy?
On the numbers, Care Ratings (CARERATING) worth a closer look, a Downstox Snapshot Score of 66/100, weighing premium at 30.2× earnings, ROE of 19.7%, a 68% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is CARERATING overvalued or undervalued?
CARERATING trades at 30.2× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the CARERATING share price target for 2031?
CARERATING's probability-weighted 2031 median target is ₹4,069, with an 80% range of ₹1,333–₹11,865 (10,000-path Monte-Carlo).
What is the probability CARERATING doubles in 5 years?
The modelled probability of CARERATING reaching ₹3,427 (2×) within 5 years is 58%.
What is the bull case for CARERATING?
High return on equity (19.7%), the business compounds shareholder capital efficiently, the hallmark of a quality franchise. Strong ROCE (26.3%) shows the core business earns well above its cost of capital. A 10,000-path probability model puts a 68% chance the price is higher in a year, with a median target of ₹2,038 (+19%).
What are the risks in CARERATING?
At 30.2× earnings the stock carries a premium to the market, strong growth is already in the price, so any miss tends to be punished.